Integer (NYSE:ITGR) Shares Gap Up Following Better-Than-Expected Earnings

Integer Holdings Corporation (NYSE:ITGR)’s share price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $86.48, but opened at $100.00. Integer shares last traded at $91.5840, with a volume of 488,245 shares changing hands.

The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business had revenue of $472.06 million for the quarter, compared to the consensus estimate of $462.73 million. During the same period in the previous year, the firm earned $1.43 EPS. The business’s revenue was up 5.0% on a year-over-year basis. Integer has set its FY 2026 guidance at 6.290-6.780 EPS.

Integer announced that its Board of Directors has authorized a share buyback plan on Tuesday, November 4th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

Trending Headlines about Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.76 vs. $1.70 est and revenue $472.1M vs. $462.7M; full-year results showed 8% sales growth and strong adjusted EPS growth, supporting the company narrative of improving margins and growth execution. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Truist raised its price target to $97 and kept a “buy” rating, signaling an analyst view of meaningful upside versus the current level. Benzinga — Truist raises target
• Neutral Sentiment: Wells Fargo also raised its target (to $84) but kept an “equal weight” rating — a modest signal that the stock is fairly valued near current levels rather than a clear endorsement. Benzinga — Wells Fargo raises target
• Neutral Sentiment: Full earnings materials (slide deck and call transcript) are available for deeper review of segment trends, backlog and margin drivers — useful for investors deciding if the beat is sustainable. Q4 Results – Earnings Call Presentation Q4 Earnings Call Transcript
• Negative Sentiment: Market reaction was mixed: some investors sold after management’s FY2026 guidance was viewed as softer than hoped, leading to an earlier pullback. Zacks notes shares fell despite the beat because guidance tempered enthusiasm. ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
• Negative Sentiment: Wider context: guidance midpoint and revenue outlook left some analysts noting modest downside risk versus certain targets, which could cap upside until visibility improves. MarketBeat — Earnings & Guidance Details

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Bank of America downgraded Integer from a “buy” rating to a “neutral” rating and set a $87.00 target price for the company. in a research report on Friday, October 24th. Benchmark reissued a “hold” rating on shares of Integer in a research note on Friday, October 24th. Truist Financial upped their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday. Wells Fargo & Company raised their price target on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday. Finally, Argus downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.25.

Hedge Funds Weigh In On Integer

Large investors have recently bought and sold shares of the business. Salomon & Ludwin LLC purchased a new stake in Integer during the 3rd quarter worth about $26,000. Global Retirement Partners LLC raised its position in shares of Integer by 293.8% during the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 238 shares in the last quarter. TD Private Client Wealth LLC lifted its stake in Integer by 1,037.5% during the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 415 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares in the last quarter. Finally, Arax Advisory Partners increased its stake in Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 473 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Trading Up 2.2%

The company has a market cap of $2.97 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 0.76 and a beta of 0.77. The company has a quick ratio of 2.45, a current ratio of 3.32 and a debt-to-equity ratio of 0.69. The business’s fifty day simple moving average is $82.83 and its two-hundred day simple moving average is $88.25.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.